Gastroenterology Firm Turns to AI Technology Solutions to Enhance Efficiency and Patient Care
Gastroenterology Firm Turns to AI Technology...
Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related Diseases
Shift Bioscience Bags $16m to Develop Novel Therapies for Age-related DiseasesShift Bioscience, a biotechnology startup using generative AI to explore how gene activation can reverse the aging process, has secured $16 million in seed funding to further develop its cell simulation AI platform. The funding round was led by BGF, with significant contributions from Kindred Capital, F-Prime Capital, and Jonathan Milner.
Please login to comment on this Post